Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Rook

Showing results (101-110 of 192) with videos related to

Pageof 20
Sort By:
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 1, 1993
Specificity of primers based on IS6110 to Mycobacterium tuberculosis complex DNAH Fidler, G A Rook, N M Johnson, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 1, 1996
Raised levels of agalactosyl IgG in childhood tuberculosisC Pilkington, M Basaran, I Barlan, et al.
Autoimmunity|January 1, 1995
Agalactosyl IgG and antibody specificity in rheumatoid arthritis, tuberculosis, systemic lupus erythematosus and myasthenia gravisC Pilkington, E Yeung, D Isenberg, et al.
Immunological Reviews|June 1, 1991
Is there a role for mycobacteria in the etiopathogenesis of rheumatoid arthritis?P M Lydyard, G A Rook, G Tsoulfa, et al.
Leprosy Review|September 1, 1984
A further investigation of skin-test responsiveness and suppression in leprosy patients and healthy school children in NepalA Morton, P Nye, G A Rook, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 2001
Interleukin-4 and its alternatively spliced variant (IL-4delta2) in patients with atopic asthmaG T Seah, P S Gao, J M Hopkin, et al.
Clinical and Experimental Immunology|January 1, 1986
Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donorsG A Rook, J Steele, S Barnass, et al.
Journal of Applied Microbiology|January 7, 1998
Variation within Mycobacterium scrofulaceumA D Khosravi, J L Stanford, H D Donoghue, et al.
Immunology|December 1, 1992
The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of tumour necrosis factorE A Filley, H A Bull, P M Dowd, et al.
Respiratory Medicine|March 1, 1995
Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in AfricaP C Onyebujoh, T Abdulmumini, S Robinson, et al.
Pageof 20

Showing results (101-110 of 192) with videos related to

Sort By:
Pageof 20
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 1, 1993
Specificity of primers based on IS6110 to Mycobacterium tuberculosis complex DNAH Fidler, G A Rook, N M Johnson, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 1, 1996
Raised levels of agalactosyl IgG in childhood tuberculosisC Pilkington, M Basaran, I Barlan, et al.
Autoimmunity|January 1, 1995
Agalactosyl IgG and antibody specificity in rheumatoid arthritis, tuberculosis, systemic lupus erythematosus and myasthenia gravisC Pilkington, E Yeung, D Isenberg, et al.
Immunological Reviews|June 1, 1991
Is there a role for mycobacteria in the etiopathogenesis of rheumatoid arthritis?P M Lydyard, G A Rook, G Tsoulfa, et al.
Leprosy Review|September 1, 1984
A further investigation of skin-test responsiveness and suppression in leprosy patients and healthy school children in NepalA Morton, P Nye, G A Rook, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 2001
Interleukin-4 and its alternatively spliced variant (IL-4delta2) in patients with atopic asthmaG T Seah, P S Gao, J M Hopkin, et al.
Clinical and Experimental Immunology|January 1, 1986
Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donorsG A Rook, J Steele, S Barnass, et al.
Journal of Applied Microbiology|January 7, 1998
Variation within Mycobacterium scrofulaceumA D Khosravi, J L Stanford, H D Donoghue, et al.
Immunology|December 1, 1992
The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of tumour necrosis factorE A Filley, H A Bull, P M Dowd, et al.
Respiratory Medicine|March 1, 1995
Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in AfricaP C Onyebujoh, T Abdulmumini, S Robinson, et al.
Pageof 20